Home » Topics » BioWorld Science

BioWorld Science
RSS

Janssen files for lower-dose risperidone in U.S.

Dec. 12, 1996

Procept's topical microbicide enters phase I in Europe

Dec. 12, 1996

Millennium/Lilly's gene-based assay for atherosclerosis

Dec. 12, 1996

GastroMARK approved for marketing by FDA

Dec. 12, 1996

hu1124 advances to clinical studies

Dec. 12, 1996

EchoGen Emulsion initial trial results in prostate disease revealed

Dec. 12, 1996

Drugs quicker to reach market in U.S. than in Germany and Japan

Dec. 12, 1996

Daiichi claims LTD4 antagonists for treating allergic diseases

Dec. 12, 1996

Italian researchers described novel anti-HIV compounds

Dec. 12, 1996

Novel dual-action compounds described by Abbott

Dec. 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 3, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...